Guided Etoposide Dosing in Children
Author Information
Author(s): SP Lowis, L Price, ADJ Pearson, DR Newell, M Cole
Primary Institution: Royal Victoria Infirmary, Newcastle upon Tyne, UK
Hypothesis
Can pharmacokinetically guided dosing of etoposide improve treatment accuracy in children?
Conclusion
Pharmacokinetically guided dosing of etoposide is feasible and can achieve target AUC values with high precision.
Supporting Evidence
- Target AUC values were achieved with a mean error of 11%.
- Pharmacokinetic parameters showed less interpatient variability than previously reported.
- Adaptive dosing was successfully performed in all nine patients.
Takeaway
Doctors can adjust the amount of medicine given to kids based on how their bodies process it, making treatment more accurate.
Methodology
Nine pediatric patients received etoposide, with doses adjusted based on the day-1 AUC measured using a limited sampling model.
Potential Biases
Potential bias due to the small number of patients and the specific conditions of the study.
Limitations
The study involved a small sample size and may not be generalizable to all pediatric patients.
Participant Demographics
Six male and three female patients, aged between 2 and 18 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website